Please use this identifier to cite or link to this item: https://hdl.handle.net/10137/11779
Title: Developing and user testing new pharmacy label formats-A study to inform labelling standards.
Authors: Tong, Vivien
Aslani, Parisa
Raynor, David K
Shipp, Diana
Parkinson, Brian
Lalor, Daniel
Sobey, Andrew
Gilbert, Alice
Crofton, Jackie
Young, Joanne
Carter, Sophie
Poon, Wing
Chitlangia, Shrada
Citation: © 2021 The Authors. Health Expectations published by John Wiley & Sons Ltd.
Health Expect. 2021 Jun 2. doi: 10.1111/hex.13203.
Abstract: BACKGROUND: Dispensed prescription medicine labels (prescription labels) are important information sources supporting safe and appropriate medicines use. OBJECTIVE: To develop and user test patient-centred prescription label formats. METHODS: Five stages: developing 12 labels for four fictitious medicines of varying dosage forms; diagnostic user testing of labels (Round 1) with 40 consumers (each testing three labels); iterative label revision, and development of Round 2 labels (n = 7); user testing of labels (Round 2) with 20 consumers (each testing four labels); labelling recommendations. Evaluated labels stated the active ingredient and brand name, using various design features (eg upper case and bold). Dosing was expressed differently across labels: frequency of doses/day, approximate times of day (eg morning), explicit times (eg 7 to 9 AM), and/or explicit dosing interval. Participants' ability to find and understand medicines information and plan a dosing schedule were assessed. RESULTS: Participants demonstrated satisfactory ability to find and understand the dosage for all label formats. Excluding active ingredient and dosing schedule, 14/19 labels (8/12 in Round 1; 6/7 in Round 2) met industry standard on performance. Participants' ability to correctly identify the active ingredient varied, with clear medicine name sign-posting enabling all participants evaluating these labels to find and understand the active ingredient. When planning a dosing schedule, doses were correctly spaced if the label stated a dosing interval, or frequency of doses/day. Two-thirds planned appropriate dosing schedules using a dosing table. CONCLUSIONS: Effective prescription label formatting and sign-posting of active ingredient improved communication of information on labels, potentially supporting safe medicines use. PATIENT AND PUBLIC INVOLVEMENT: Consumers actively contributed to the development of dispensed prescription medicine labels. Feedback from consumers following the first round was incorporated in revisions of the labels for the next round. Patient and public involvement in this study was critical to the development of readable and understandable dispensed prescription medicine labels.
Click to open Pubmed Article: https://www.ezpdhcs.nt.gov.au/login?url=https://www.ncbi.nlm.nih.gov/pubmed/34076940
Journal title: Health expectations : an international journal of public participation in health care and health policy
Publication Date: 2021-06-02
Type: Journal Article
URI: https://hdl.handle.net/10137/11779
DOI: 10.1111/hex.13203
Orcid: 0000-0003-4869-7364
0000-0002-7976-8236
0000-0003-0306-5275
Appears in Collections:(a) NT Health Research Collection

Files in This Item:
There are no files associated with this item.


Items in ePublications are protected by copyright, with all rights reserved, unless otherwise indicated.

Google Media

Google ScholarTM

Who's citing

Pubmed

PubMed References

Who's citing